Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	3,735	1,823	726	25	410	372
Market Cap Growth	888.65%	151.13%	2844.89%	-93.98%	10.23%	-19.08%
Enterprise Value	3,241	1,490	354.01	-12.58	367.66	318.81
Last Close Price	61.93	30.31	19.39	20.40	28.44	25.80
PE Ratio	-	-16.38	-5.01	-4.59	-3.43	-1.55
PB Ratio	6.42	3.86	1.90	0.67	9.83	7.28
P/TBV Ratio	6.23	2.93	0.85	0.66	0.82	0.59
P/FCF Ratio	-	-20.62	-	-4.92	-37.55	-19.77
P/OCF Ratio	-	-20.67	-	-4.92	-37.56	-19.82
EV/EBITDA Ratio	-	-12.22	-	1.73	-34.76	-16.50
EV/EBIT Ratio	-	-12.21	-	1.72	-34.70	-16.49
EV/FCF Ratio	-	-16.86	-	2.51	-33.69	-16.95
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.01	0.01
Debt / EBITDA Ratio	-0.01	-0.02	-	-0.03	-0.03	-0.02
Debt / FCF Ratio	-0.02	-0.02	-	-0.04	-0.03	-0.02
Net Debt / Equity Ratio	-0.79	-0.71	-0.98	-1.01	-1.01	-1.04
Net Debt / EBITDA Ratio	2.90	2.75	-	5.11	3.99	2.74
Net Debt / FCF Ratio	4.24	3.79	-	7.43	3.86	2.82
Quick Ratio	23.38	21.92	28.80	58.76	37.50	15.25
Current Ratio	23.76	22.37	28.89	59.01	37.72	15.56
Return on Equity (ROE)	-24.25%	-24.69%	0.00%	-13.57%	-21.41%	-39.61%
Return on Assets (ROA)	-26.87%	-27.59%	0.00%	-18.03%	-21.62%	-36.71%
Return on Invested Capital (ROIC)	-111.38%	-162.31%	0.00%	19718.90%	1177.33%	949.19%
Return on Capital Employed (ROCE)	-27.76%	-28.51%	0.00%	-18.43%	-22.69%	-39.32%
Earnings Yield	-2.52%	-6.10%	-19.96%	-21.76%	-29.11%	-64.65%
FCF Yield	-2.44%	-4.85%	0.00%	-20.34%	-2.66%	-5.06%
Buyback Yield / Dilution	-85.49%	-171.68%	-1297.58%	-0.04%	-3.64%	-195.18%
Total Shareholder Return	-85.49%	-171.68%	-1297.58%	-0.04%	-3.64%	-195.18%

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q